Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population

G. M. Horowitz, R. T. Scott, Gary Hankins

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A prenatal screening program for antibody to the human immunodeficiency virus (HIV) was examined prospectively in a cross-sectional population. Routine screening was performed on 3,241 women during the first trimester. Serum samples yielding repeatedly positive results on an enzyme-linked immunosorbent assay (ELISA) (n=6) were subjected to confirmatory Western blot testing. All the specimens were determined to be false positive with atypical banding regions not consistent with HIV-1 infection. This false-positive rate was higher than in previous reports of screening programs in low-risk populations (P < .005). Since antibody to HIV may not be detectable for several months after infection, we serially tested 984 of the women in different trimesters of pregnancy to determine whether repeat testing would yield seroconversion undetected at the first screening. No patient who initially tested negative on the ELISA tested positive later in gestation. We therefore recommend that routine screening be performed only once during pregnancy, preferably in the first or early second trimester, in the general population.

Original languageEnglish (US)
Pages (from-to)773-778
Number of pages6
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume36
Issue number11
StatePublished - 1991
Externally publishedYes

Fingerprint

Prenatal Diagnosis
HIV
Enzyme-Linked Immunosorbent Assay
Population
Pregnancy Trimesters
Pregnancy
Antibodies
Second Pregnancy Trimester
Virus Diseases
First Pregnancy Trimester
HIV-1
Western Blotting
Infection
Serum

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population. / Horowitz, G. M.; Scott, R. T.; Hankins, Gary.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 36, No. 11, 1991, p. 773-778.

Research output: Contribution to journalArticle

@article{30593859cea44d40a2a4ec3d6858f210,
title = "Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population",
abstract = "A prenatal screening program for antibody to the human immunodeficiency virus (HIV) was examined prospectively in a cross-sectional population. Routine screening was performed on 3,241 women during the first trimester. Serum samples yielding repeatedly positive results on an enzyme-linked immunosorbent assay (ELISA) (n=6) were subjected to confirmatory Western blot testing. All the specimens were determined to be false positive with atypical banding regions not consistent with HIV-1 infection. This false-positive rate was higher than in previous reports of screening programs in low-risk populations (P < .005). Since antibody to HIV may not be detectable for several months after infection, we serially tested 984 of the women in different trimesters of pregnancy to determine whether repeat testing would yield seroconversion undetected at the first screening. No patient who initially tested negative on the ELISA tested positive later in gestation. We therefore recommend that routine screening be performed only once during pregnancy, preferably in the first or early second trimester, in the general population.",
author = "Horowitz, {G. M.} and Scott, {R. T.} and Gary Hankins",
year = "1991",
language = "English (US)",
volume = "36",
pages = "773--778",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "11",

}

TY - JOUR

T1 - Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population

AU - Horowitz, G. M.

AU - Scott, R. T.

AU - Hankins, Gary

PY - 1991

Y1 - 1991

N2 - A prenatal screening program for antibody to the human immunodeficiency virus (HIV) was examined prospectively in a cross-sectional population. Routine screening was performed on 3,241 women during the first trimester. Serum samples yielding repeatedly positive results on an enzyme-linked immunosorbent assay (ELISA) (n=6) were subjected to confirmatory Western blot testing. All the specimens were determined to be false positive with atypical banding regions not consistent with HIV-1 infection. This false-positive rate was higher than in previous reports of screening programs in low-risk populations (P < .005). Since antibody to HIV may not be detectable for several months after infection, we serially tested 984 of the women in different trimesters of pregnancy to determine whether repeat testing would yield seroconversion undetected at the first screening. No patient who initially tested negative on the ELISA tested positive later in gestation. We therefore recommend that routine screening be performed only once during pregnancy, preferably in the first or early second trimester, in the general population.

AB - A prenatal screening program for antibody to the human immunodeficiency virus (HIV) was examined prospectively in a cross-sectional population. Routine screening was performed on 3,241 women during the first trimester. Serum samples yielding repeatedly positive results on an enzyme-linked immunosorbent assay (ELISA) (n=6) were subjected to confirmatory Western blot testing. All the specimens were determined to be false positive with atypical banding regions not consistent with HIV-1 infection. This false-positive rate was higher than in previous reports of screening programs in low-risk populations (P < .005). Since antibody to HIV may not be detectable for several months after infection, we serially tested 984 of the women in different trimesters of pregnancy to determine whether repeat testing would yield seroconversion undetected at the first screening. No patient who initially tested negative on the ELISA tested positive later in gestation. We therefore recommend that routine screening be performed only once during pregnancy, preferably in the first or early second trimester, in the general population.

UR - http://www.scopus.com/inward/record.url?scp=0025935341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025935341&partnerID=8YFLogxK

M3 - Article

C2 - 1765954

AN - SCOPUS:0025935341

VL - 36

SP - 773

EP - 778

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 11

ER -